PathAI and ConcertAI Partner to Create First-in-Class Histopathology and Clinical Real-World Data Solutions
Researchers derive novel insights through the combination of PathAI’s proprietary tumor microenvironment features with ConcertAI’s multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ — PathAI, a global leader in AI-powered pathology, and ConcertAI, a leader...